Although Austria’s healthcare sector has good infrastructure and high standards, there is increasing momentum towards greater efficiency and reform while increasing quality.
Tensions within the Austrian healthcare system derive from the increasing awareness of patients, who demand quality at the highest level, rising cost pressure from federal and state governments, and conflicts of interest between stakeholders.
Due to the diversity of services in combination with only moderate returns, the healthcare industry brings many risks, but there are also opportunities for companies to position and establish themselves within the market.
Like healthcare companies, the Austrian pharmaceutical industry also needs to increase transparency and implement regulations such as the Austrian Medicines Act or the Pharmig Code of Conduct. Within these frameworks, pharmaceutical companies must react to cost-cutting plans, caused by financing problems within the Austrian healthcare system.
New technologies, personalised medicine, and the financing of medical innovations: The demands on the industry are increasing. Our experts know the challenges and opportunities and develop sustainable solutions.
PwC's Pharma and Healthcare team offers a comprehensive range of services in the areas of auditing, tax consulting, and advisory. Whether you have questions about transfer pricing, want to convert your annual financial statements to IFRS, or need to calculate the profitability of healthcare facilities, we can help.